Travere Therapeutics, Inc. (TVTX)
26.53
-0.26
(-0.97%)
USD |
NASDAQ |
Mar 25, 11:20
Travere Therapeutics EPS Diluted (Quarterly) : -0.2435 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Revolution Medicines, Inc. | -1.855 |
| ICU Medical, Inc. | -0.6373 |
| Tandem Diabetes Care, Inc. | -0.0087 |
| iRhythm Holdings, Inc. | 0.1674 |
| Eli Lilly & Co. | 7.024 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.99M |
| Revenue (Quarterly) | 129.69M |
| Total Expenses (Quarterly) | 151.68M |
| Enterprise Value | 2.477B |
| Gross Profit Margin (Quarterly) | 84.05% |
| Profit Margin (Quarterly) | -16.95% |
| Earnings Yield | -2.27% |
| Normalized Earnings Yield | -2.273 |